Drug Search Results
More Filters [+]

Fenoterol

Alternative Names: fenoterol, berotec, fenoterolhydrobromid, berodual
Latest Update: 2023-12-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRB2 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Inhalant,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Czech | Denmark | Dominican Republic | Egypt | Estonia | Finland | France | Germany | Greece | Hungary | Indonesia | Ireland | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Mexico | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Sweden | Switzerland | Taiwan | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fenoterol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events